Cigarette smoke attenuates mesenchymal stem cell-based suppression of immune cell-driven acute liver failure.

Pavlovic, Dragica; Miloradovic, Dragana; Stojanovic, Milica Dimitrijevic; Harrell, Carl Randall; Polosa, Riccardo; Rust, Sonja; Volti, Giovanni Li; Caruso, Massimo; Jakovljevic, Vladimir; Djonov, Valentin; Volarevic, Vladislav (2023). Cigarette smoke attenuates mesenchymal stem cell-based suppression of immune cell-driven acute liver failure. Toxicology letters, 385, pp. 12-20. Elsevier 10.1016/j.toxlet.2023.08.006

[img]
Preview
Text
s00415-023-11902-z.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (842kB) | Preview

Detrimental effects of smoking on mesenchymal stem cell (MSC)-dependent immunosuppression and hepatoprotection are unknown. Herewith, by using α-galactosylceramide (α-GalCer)-induced liver injury, a well-established murine model of fulminant hepatitis, we examined molecular mechanisms which were responsible for negative effects of cigarette smoke on MSC-dependent immunomodulation. MSC which were grown in cigarette smoke-exposed medium (MSCWS-CM) obtained pro-inflammatory phenotype, were not able to optimally produce hepatoprotective and immunosuppressive cytokines (TGF-β, HGF, IL-10, NO, KYN), and secreted significantly higher amounts of inflammatory cytokines (IFN-γ, TNF-α, IL-17, IL-6) than MSC that were cultured in standard medium never exposed to cigarette smoke (MSCCM). In contrast to MSCCM, which efficiently attenuated α-GalCer-induced hepatitis, MSCWS-CM were not able to prevent hepatocyte injury and liver inflammation. MSCWS-CM had reduced capacity for the suppression of liver-infiltrated inflammatory macrophages, dendritic cells (DCs) and lymphocytes. Although significantly lower number of IL-12-producing macrophages and DCs, TNF-α, IFN-γ or IL-17-producing CD4+ and CD8+T lymphocytes, NK and NKT cells were noticed in the livers of α-GalCer+MSCCM-treated mice compared to α-GalCer+saline-treated animals, this phenomenon was not observed in α-GalCer-injured mice that received MSCWS-CM. MSCWS-CM could not induce expansion of anti-inflammatory IL-10-producing FoxP3+CD4+ and CD8+ T regulatory cells and were not able to create immunosuppressive microenvironment in the liver as MSCCM. Similarly as it was observed in mice, MSCWS-CM were not able to optimally inhibit production of inflammatory and hepatototoxic cytokines in activated human Th1/Th17 and NKT1/NKT17 cells, confirming the hypothesis that cigarette smoke significantly attenuates therapeutic potential of MSC in cell-based immunotherapy of inflammatory liver diseases.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy

UniBE Contributor:

Djonov, Valentin Georgiev

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0378-4274

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

14 Aug 2023 12:23

Last Modified:

11 Aug 2024 00:25

Publisher DOI:

10.1016/j.toxlet.2023.08.006

PubMed ID:

37572970

Uncontrolled Keywords:

acute hepatitis cigarette smoke hepatoprotection immunosuppression mesenchymal stem cells therapy

BORIS DOI:

10.48350/185429

URI:

https://boris.unibe.ch/id/eprint/185429

Actions (login required)

Edit item Edit item
Provide Feedback